Levosimendan
- PDF / 141,122 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 101 Downloads / 176 Views
1
Levosimendan Pulmonary hypertension in an elderly patient: case report A 70-year-old man, who had severe aortic valve stenosis and coronary artery disease, underwent aortic valve replacement and a double coronary bypass. During his second hour in ICU, because of pre-existing heart failure, he started receiving levosimendan at a dose of 24 µg over 10 minutes followed by 0.1 µg/kg/min in a continuous infusion over 24 hours. After the initial loading dose and about 2 hours of treatment, his pulmonary artery pressure increased markedly. Within half an hour, his mean pulmonary artery pressure had increased to 53 mmHg from a baseline value of 29 mmHg. Levosimendan was stopped and, within 1 hour, his pulmonary artery pressure normalised without specific treatment. His postoperative course was uneventful. Author comment: "[W]e attributed the [pulmonary artery pressure] elevation to a paradoxical action of levosimendan". Tagarakis GI, et al. Can pulmonary artery hypertension be attributed to levosimendan? A problematic based on a patient’s case. Journal of Cardiovascular Medicine 11: 552-553, No. 7, Jul 2010. Available from: URL: http:// 803032055 dx.doi.org/10.2459/jcm.0b013e32833668a9 - Greece
0114-9954/10/1314-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved
Reactions 14 Aug 2010 No. 1314
Data Loading...
